Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial

BACKGROUND: Human papillomavirus (HPV) is one of the most significant risk factors for cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical cancer. The present study aimed to investigate the impact of prophylactic quadrivalent HPV vaccine in the treatment of wo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Public Health
Hoofdauteurs: Karimi-Zarchi, Mojgan, Allahqoli, Leila, Nehmati, Ameneh, Kashi, Abolfazl Mehdizadeh, Taghipour-Zahir, Shokouh, Alkatout, Ibrahim
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2020
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7045378/
https://ncbi.nlm.nih.gov/pubmed/32106837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-020-8371-z
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items